TD Cowen raises Halozyme Therapeutics' target price to $130 from $105
HALO•TD Cowen raised its target price for Halozyme Therapeutics to $130 from $105.
Related News
nVent partners with AMD to add rack-level cooling to Helios AI platform
NVT•
Absci to report Q3 2026 results, host conference call
ABSI•
S&P Dow Jones Indices, Kaiko complete first on-chain OTC swap tied to tokenized iBoxx credit index
SPGI•
Anterix CFO Elena Marquez disposes of $400,702 in common shares
ATEX•
Super League Enterprise buys one bitcoin for $83,041.40
SLE•